Board meeting outcome
Awaiting price reaction for this filing.
Dolphin Medical Services filed audited Q4 and full-year FY25 results on April 12, 2025. Revenue from operations rose about 15% YoY to Rs. 77.94 lakhs (FY24: Rs. 67.86 lakhs), with total income at Rs. 81.62 lakhs. The company posted a net loss of Rs. 3.38 lakhs for FY25, a significant improvement from a Rs. 10.40 lakh loss in FY24, though Q4 alone saw a Rs. 7 lakh loss. Reserves remain deeply negative at Rs. (506.04) lakhs, reflecting years of accumulated losses, and operating cash flow was negative at Rs. (5.97) lakhs. The statutory auditor issued an unmodified opinion on the results.
Mildly positive that losses are narrowing and revenue is growing, but shareholders should note that the company continues to burn cash, has heavily eroded reserves, and operates at a very small scale, making it a high-risk micro-cap.